Cited by 624Renin-Angiotensin System StudiesCoagulation, Bradykinin, Polyphosphates, and AngioedemaEicosanoids and Hypertension Pharmacology

The DOI matches its Crossref record; 85 of the 85 references it cites were found in a registry or an index.

Angiotensin-Converting Enzyme 2 (ACE2) Is a Key Modulator of the Renin Angiotensin System in Health and Disease

Open access

Tikellis, Chris, Thomas, M. C.·2012·International Journal of Peptides

DOI 10.1155/2012/256294PMC PMC3321295

Open this paper in CoChat — free account Open PDF

Abstract

Angiotensin-converting enzyme 2 (ACE2) shares some homology with angiotensin-converting enzyme (ACE) but is not inhibited by ACE inhibitors. The main role of ACE2 is the degradation of Ang II resulting in the formation of angiotensin 1–7 (Ang 1–7) which opposes the actions of Ang II. Increased Ang II levels are thought to upregulate ACE2 activity, and in ACE2 deficient mice Ang II levels are approximately double that of wild-type mice, whilst Ang 1–7 levels are almost undetectable. Thus, ACE2 plays a crucial role in the RAS because it opposes the actions of Ang II. Consequently, it has a beneficial role in many diseases such as hypertension, diabetes, and cardiovascular disease where its expression is decreased. Not surprisingly, current therapeutic strategies for ACE2 involve augmenting its expression using ACE2 adenoviruses, recombinant ACE2 or compounds in these diseases thereby affording some organ protection.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1155/2012/256294

Cites

85 of 85 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Angiotensin-converting enzyme 2 is a functional receptor for the SARS coronavirus
Li, W., Moore, M. J., Vasilieva, N., Sui, J., Wong, S. K., Berne, M. A., Somasundaran, M., Sullivan, J. L., Luzuriaga, K., Greenough, T. C., et al. (2003) · Nature · doi:10.1038/nature02145 · Cited by 5,923
Effect of Captopril on Mortality and Morbidity in Patients with Left Ventricular Dysfunction after Myocardial Infarction: Results of the Survival and Ventricular Enlargement Trial
Pfeffer, M. A., Braunwald, E., Moyé, L. A., Basta, L., Brown, E. J., Cuddy, T. E., Davis, B. R., Geltman, E. M., Goldman, S., Flaker, G. C., et al. (1992) · New England Journal of Medicine · doi:10.1056/nejm199209033271001 · Cited by 5,911
A crucial role of angiotensin converting enzyme 2 (ACE2) in SARS coronavirus–induced lung injury
Kuba, K., Imai, Y., Rao, S., Gao, H., Guo, F., Guan, B., Huan, Y., Yang, P., Zhang, Y., Deng, W., et al. (2005) · Nature Medicine · doi:10.1038/nm1267 · Cited by 3,445
A Novel Angiotensin-Converting Enzyme–Related Carboxypeptidase (ACE2) Converts Angiotensin I to Angiotensin 1-9
Donoghue, M., Hsieh, F., Baronas, E., Godbout, K., Gosselin, M., Stagliano, N., Donovan, M., Woolf, B., Robison, K., Jeyaseelan, R., et al. (2000) · Circulation Research · doi:10.1161/01.res.87.5.e1 · Cited by 2,485
Angiotensin-converting enzyme 2 protects from severe acute lung failure
Imai, Y., Kuba, K., Rao, S., Huan, Y., Guo, F., Guan, B., Yang, P., Sarao, R., Wada, T., Leong-Poi, H., et al. (2005) · Nature · doi:10.1038/nature03712 · Cited by 2,453
A Human Homolog of Angiotensin-converting Enzyme
Tipnis, S. R., Hooper, N. M., Hyde, R., Karran, E. H., Christie, G., & Turner, A. J. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m002615200 · Cited by 2,041
Angiotensin-converting enzyme 2 is an essential regulator of heart function
Crackower, M. A., Sarao, R., Oudit, G. Y., Yagil, C., Kozieradzki, I., Scanga, S. E., Oliveira-dos-Santos, A. J., da Costa, J., Zhang, L., Pei, Y., et al. (2002) · Nature · doi:10.1038/nature00786 · Cited by 1,733
Hydrolysis of Biological Peptides by Human Angiotensin-converting Enzyme-related Carboxypeptidase
Vickers, C., Hales, P., Kaushik, V. K., Dick, L. R., Gavin, J. M., Tang, J., Godbout, K., Parsons, T. F., Baronas, E., Hsieh, F., et al. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m200581200 · Cited by 1,406
Autocrine release of angiotensin II mediates stretch-induced hypertrophy of cardiac myocytes in vitro
Sadoshima, J.-I., Xu, Y., Slayter, H. S., & Izumo, S. (1993) · Cell · doi:10.1016/0092-8674(93)90541-w · Cited by 1,348
Angiotensin II induces smooth muscle cell proliferation in the normal and injured rat arterial wall.
Daemen, M. J. A. P., Lombardi, D. M., Bosman, F. T., & Schwartz, S. M. (1991) · Circulation Research · doi:10.1161/01.res.68.2.450 · Cited by 738

Flagged first, then by citations

Show all 85 references

Research works printed but not linked: 4

2000, Circulation Research, 87, E1
2002, American Journal of Physiology, 282, H2254
1993, Circulation, 87, IV7
1994, Hypertension, 23, 869

Sorted by citations

COVID-19 and cardiovascular disease
Clerkin, K. J., Fried, J. A., Raikhelkar, J., Sayer, G., Griffin, J. M., Masoumi, A., Jain, S. S., Burkhoff, D., Kumaraiah, D., Rabbani, L., et al. (2020) · Circulation · doi:10.1161/circulationaha.120.046941 · Cited by 1,738
The pivotal link between ACE2 deficiency and SARS-CoV-2 infection
Verdecchia, P., Cavallini, C., Spanevello, A., & Angeli, F. (2020) · European Journal of Internal Medicine · doi:10.1016/j.ejim.2020.04.037 · Cited by 1,237
“[61-63] Several experimental and clinical studies indicate that ACE2 deficiency obtained through deletion or inhibition may be a causative factor for hypertension.”
Angiotensin‐converting enzyme 2 ( ACE2 ), SARS‐CoV ‐2 and the pathophysiology of coronavirus disease 2019 ( COVID ‐19)
Bourgonje, A. R., Abdulle, A. E., Timens, W., Hillebrands, J., Navis, G. J., Gordijn, S. J., Bolling, M. C., Dijkstra, G. D. H., Voors, A. A., Osterhaus, A. D. M. E., et al. (2020) · The Journal of Pathology · doi:10.1002/path.5471 · Cited by 1,160
Health benefits of polyphenols: A concise review
Rana, A., Samtiya, M., Dhewa, T., Mishra, V., & Aluko, R. E. (2022) · Journal of Food Biochemistry · doi:10.1111/jfbc.14264 · Cited by 840
The hypercoagulable state in COVID-19: Incidence, pathophysiology, and management
Abou-Ismail, M. Y., Diamond, A., Kapoor, S., Arafah, Y., & Nayak, L. (2020) · Thrombosis Research · doi:10.1016/j.thromres.2020.06.029 · Cited by 694
Age-Related Morbidity and Mortality among Patients with COVID-19
Kang, S., & Jung, S. (2020) · Infection and Chemotherapy · doi:10.3947/ic.2020.52.2.154 · Cited by 537
A comprehensive review of COVID-19 characteristics
Esakandari, H., Nabi‐Afjadi, M., Afjadi, J. F., Farahmandian, N., Miresmaeili, S. M., & Bahreini, E. (2020) · Biological Procedures Online · doi:10.1186/s12575-020-00128-2 · Cited by 511
Physical exercise as a tool to help the immune system against COVID-19: an integrative review of the current literature
da Silveira, M. P., da Silva Fagundes, K. K., Bizuti, M. R., Starck, É., Rossi, R. C., & de Resende e Silva, D. T. (2021) · Clinical and Experimental Medicine · doi:10.1007/s10238-020-00650-3 · Cited by 475
Clinical Characteristics of Covid-19 in China
Chen, A. T. C., Coura-Filho, G. B., & Rehder, M. H. H. (2020) · New England Journal of Medicine · doi:10.1056/nejmc2005203 · Cited by 481
COVID-19 and Individual Genetic Susceptibility/Receptivity: Role of ACE1/ACE2 Genes, Immunity, Inflammation and Coagulation. Might the Double X-Chromosome in Females Be Protective against SARS-CoV-2 Compared to the Single X-Chromosome in Males?
Gemmati, D., Bramanti, B., Serino, M. L., Secchiero, P., Zauli, G., & Tisato, V. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21103474 · Cited by 409
Hyperinflammation and derangement of renin-angiotensin-aldosterone system in COVID-19: A novel hypothesis for clinically suspected hypercoagulopathy and microvascular immunothrombosis
Henry, B. M., Vikse, J., Benoit, S. W., Favaloro, E. J., & Lippi, G. (2020) · Clinica Chimica Acta · doi:10.1016/j.cca.2020.04.027 · Cited by 381
ACE2, Much More Than Just a Receptor for SARS-COV-2
Samavati, L., & Uhal, B. D. (2020) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2020.00317 · Cited by 374
COVID-19: breaking down a global health crisis
Mallah, S. I., Ghorab, O. K. H. A., Al-Salmi, S., Abdellatif, O. S., Tharmaratnam, T., Iskandar, M. M. A., Sefen, J. A. N., Sidhu, P., Atallah, B., El-Lababidi, R. M., et al. (2021) · Annals of Clinical Microbiology and Antimicrobials · doi:10.1186/s12941-021-00438-7 · Cited by 401
SARS-CoV-2, COVID-19 and the aging immune system
Bartleson, J. M., Radenkovic, D., Covarrubias, A. J., Furman, D., Winer, D. A., & Verdin, E. (2021) · Nature Aging · doi:10.1038/s43587-021-00114-7 · Cited by 359
COVID-19, diabetes mellitus and ACE2: The conundrum
Pal, R., & Bhansali, A. K. (2020) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2020.108132 · Cited by 359
Gastrointestinal symptoms associated with COVID-19: impact on the gut microbiome
Villapol, S. (2020) · Translational research · doi:10.1016/j.trsl.2020.08.004 · Cited by 341
Molecular mechanism of interaction between SARS-CoV-2 and host cells and interventional therapy
Zhang, Q., Xiang, R., Huo, S., Zhou, Y., Jiang, S., Wang, Q., & Yu, F. (2021) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-021-00653-w · Cited by 364
Racial Disparities-Associated COVID-19 Mortality among Minority Populations in the US
Alcendor, D. J. (2020) · Journal of Clinical Medicine · doi:10.3390/jcm9082442 · Cited by 348
COVID-19 for the Cardiologist
Atri, D. S., Siddiqi, H. K., Lang, J. P., Nauffal, V., Morrow, D. A., & Bohula, E. A. (2020) · JACC Basic to Translational Science · doi:10.1016/j.jacbts.2020.04.002 · Cited by 337
Investigation into SARS-CoV-2 Resistance of Compounds in Garlic Essential Oil
Thuý, B. T. P., My, T. T. A., Hải, N. T. T., Hiếu, L. T., Hòa, T. T., Loan, H. T. P., Triet, N. T., Anh, T. T. V., Quý, P. T., Tất, P. V., et al. (2020) · ACS Omega · doi:10.1021/acsomega.0c00772 · Cited by 318
Racial and Gender-Based Differences in COVID-19
Kopel, J. J., Perisetti, A., Roghani, A., Aziz, M., Gajendran, M., & Goyal, H. (2020) · Frontiers in Public Health · doi:10.3389/fpubh.2020.00418 · Cited by 324
COVID-19 and diabetes mellitus: An unholy interaction of two pandemics
Pal, R., & Bhadada, S. K. (2020) · Diabetes & Metabolic Syndrome Clinical Research & Reviews · doi:10.1016/j.dsx.2020.04.049 · Cited by 311
The possible pathophysiology mechanism of cytokine storm in elderly adults with COVID-19 infection: the contribution of “inflame-aging”
Meftahi, G. H., Jangravi, Z., Sahraei, H., & Bahari, Z. (2020) · Inflammation Research · doi:10.1007/s00011-020-01372-8 · Cited by 301
COVID-19 and comorbidities: a systematic review and meta-analysis
Gold, M. S., Sehayek, D., Gabrielli, S., Zhang, X., McCusker, C. T., & Ben‐Shoshan, M. (2020) · Postgraduate Medicine · doi:10.1080/00325481.2020.1786964 · Cited by 289
Body Localization of ACE-2: On the Trail of the Keyhole of SARS-CoV-2
Salamanna, F., Maglio, M., Landini, M. P., & Fini, M. (2020) · Frontiers in Medicine · doi:10.3389/fmed.2020.594495 · Cited by 298
COVID-19, Renin-Angiotensin System and Endothelial Dysfunction
Amraei, R., & Rahimi, N. (2020) · Cells · doi:10.3390/cells9071652 · Cited by 281
Heart failure and COVID-19
Bader, F. M., Manla, Y., Atallah, B., & Starling, R. C. (2020) · Heart Failure Reviews · doi:10.1007/s10741-020-10008-2 · Cited by 264
SARS-CoV-2 pandemic and research gaps: Understanding SARS-CoV-2 interaction with the ACE2 receptor and implications for therapy
Datta, P. K., Liu, F., Fischer, T., Rappaport, J., & Qin, X. (2020) · Theranostics · doi:10.7150/thno.48076 · Cited by 262
Monitoring SARS-CoV-2 Circulation and Diversity through Community Wastewater Sequencing, the Netherlands and Belgium
Izquierdo-Lara, R. W., Elsinga, G., Heijnen, L., Munnink, B. B. O., Schapendonk, C. M. E., Nieuwenhuijse, D. F., Kon, M., Lu, L., Aarestrup, F. M., Lycett, S., et al. (2021) · Emerging infectious diseases · doi:10.3201/eid2705.204410 · Cited by 217
The Immune Response and Immunopathology of COVID-19
Mortaz, E., Tabarsi, P., Varahram, M., Folkerts, G., & Adcock, I. M. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.02037 · Cited by 210
Will children reveal their secret? The coronavirus dilemma
Cristiani, L., Mancino, E., Matera, L., Nenna, R., Pierangeli, A., Scagnolari, C., & Midulla, F. (2020) · European Respiratory Journal · doi:10.1183/13993003.00749-2020 · Cited by 208
A hypothesis for pathobiology and treatment of COVID‐19 : The centrality of ACE1 / ACE2 imbalance
Sriram, K., & Insel, P. A. (2020) · British Journal of Pharmacology · doi:10.1111/bph.15082 · Cited by 196
Factors leading to high morbidity and mortality of COVID ‐19 in patients with type 2 diabetes
Rajpal, A., Rahimi, L., & Ismail‐Beigi, F. (2020) · Journal of Diabetes · doi:10.1111/1753-0407.13085 · Cited by 178
SARS-CoV-2, ACE2 expression, and systemic organ invasion
Ashraf, U., Abokor, A. A., Edwards, J. M., Waigi, E. W., Royfman, R., Hasan, S. A., Smedlund, K., Grégio, A. M. T., Chakravarti, R., & Koch, L. G. (2020) · Physiological Genomics · doi:10.1152/physiolgenomics.00087.2020 · Cited by 181
COVID-19 Clinical Characteristics, and Sex-Specific Risk of Mortality: Systematic Review and Meta-Analysis
Nasiri, M. J., Haddadi, S., Tahvildari, A., Farsi, Y., Arbabi, M., Hasanzadeh, S., Jamshidi, P. K., Murthi, M., & Mirsaeidi, M. S. (2020) · Frontiers in Medicine · doi:10.3389/fmed.2020.00459 · Cited by 170
Angiotensin-Converting Enzyme 2 and Antihypertensives (Angiotensin Receptor Blockers and Angiotensin-Converting Enzyme Inhibitors) in Coronavirus Disease 2019
Sanchis‐Gomar, F., Lavie, C. J., Pérez-Quilis, C., Henry, B. M., & Lippi, G. (2020) · Mayo Clinic Proceedings · doi:10.1016/j.mayocp.2020.03.026 · Cited by 167
Risk factors for disease progression in patients with mild to moderate coronavirus disease 2019—a multi-centre observational study
Cen, Y., Chen, X., Shen, Y., Zhang, X.-H., Lei, Y., Xu, C., Jiang, W.-R., Xu, H., Chen, Y., Zhu, J., et al. (2020) · Clinical Microbiology and Infection · doi:10.1016/j.cmi.2020.05.041 · Cited by 164
Coronavirus disease 2019 (COVID-19) outbreak: some serious consequences with urban and rural water cycle
Bhowmick, G. D., Dhar, D., Nath, D., Ghangrekar, M. M., Banerjee, R., Das, S., & Chatterjee, J. (2020) · npj Clean Water · doi:10.1038/s41545-020-0079-1 · Cited by 163
COVID-19 and the Cardiovascular System
Veer, M., Kumar, A. M., & Ivanova, V. (2020) · Critical Care Nursing Quarterly · doi:10.1097/cnq.0000000000000323 · Cited by 164
Will children reveal their secret? The coronavirus dilemma
Midulla, F., Cristiani, L., & Mancino, E. (2020) · European Respiratory Journal · doi:10.1183/13993003.01617-2020 · Cited by 158
Understanding the renin–angiotensin–aldosterone–SARS-CoV axis: a comprehensive review
Ingraham, N. E., Barakat, A., Reilkoff, R. A., Bezdicek, T. L., Schacker, T. W., Chipman, J. G., Tignanelli, C. J., & Puskarich, M. A. (2020) · European Respiratory Journal · doi:10.1183/13993003.00912-2020 · Cited by 161
The ACE-2 in COVID-19: Foe or Friend?
Dalan, R., Bornstein, S. R., El‐Armouche, A., Rodionov, R. N., Markov, A. G., Wielockx, B., Beuschlein, F., & Boehm, B. O. (2020) · Hormone and Metabolic Research · doi:10.1055/a-1155-0501 · Cited by 158
ACE2 polymorphism and susceptibility for SARS-CoV-2 infection and severity of COVID-19
Möhlendick, B., Schönfelder, K., Breuckmann, K., Elsner, C., Babel, N., Balfanz, P., Dahl, E., Dreher, M., Fistera, D., Herbstreit, F., et al. (2021) · Pharmacogenetics and Genomics · doi:10.1097/fpc.0000000000000436 · Cited by 131
Biomechanical characterization of SARS-CoV-2 spike RBD and human ACE2 protein-protein interaction
Cao, W., Dong, C., Kim, S., Hou, D., Tai, W., Du, L., Im, W., & Zhang, X. H. (2021) · Biophysical Journal · doi:10.1016/j.bpj.2021.02.007 · Cited by 128
Surgery in times of COVID-19—recommendations for hospital and patient management
Flemming, S., Hankir, M. K., Ernestus, R.-I., Seyfried, F., Germer, C.-T., Meybohm, P., Wurmb, T. E., Vogel, U. F., & Wiegering, A. (2020) · Langenbeck s Archives of Surgery · doi:10.1007/s00423-020-01888-x · Cited by 126
Clinical Insights into the Gastrointestinal Manifestations of COVID-19
Kopel, J. J., Perisetti, A., Gajendran, M., Boregowda, U. N., & Goyal, H. (2020) · Digestive Diseases and Sciences · doi:10.1007/s10620-020-06362-8 · Cited by 125
Infections and Autoimmunity—The Immune System and Vitamin D: A Systematic Review
Wimalawansa, S. J. (2023) · Nutrients · doi:10.3390/nu15173842 · Cited by 138
Alveolar epithelial cell type II as main target of SARS-CoV-2 virus and COVID-19 development via NF-Kb pathway deregulation: A physio-pathological theory
Carcaterra, M., & Caruso, C. (2020) · Medical Hypotheses · doi:10.1016/j.mehy.2020.110412 · Cited by 122
Vitamin D can prevent COVID-19 infection-induced multiple organ damage
Aygün, H. (2020) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s00210-020-01911-4 · Cited by 117
Natural Flavonoids as Potential Angiotensin-Converting Enzyme 2 Inhibitors for Anti-SARS-CoV-2
Muchtaridi, M., Fauzi, M., Ikram, N. K. K., Gazzali, A. M., & Wahab, H. A. (2020) · Molecules · doi:10.3390/molecules25173980 · Cited by 113
Smoking and COVID-19: What we know so far
Shastri, M. D., Shukla, S. D., Chong, W. C., Rajendra, K. C., Dua, K., Patel, R. P., Peterson, G. M., & O’Toole, R. (2020) · Respiratory Medicine · doi:10.1016/j.rmed.2020.106237 · Cited by 110
Pathogenesis, Clinical Manifestations and Complications of COVID-19
Kordzadeh-Kermani, E., Khalili, H., & Karimzadeh, I. (2020) · Future Microbiology · doi:10.2217/fmb-2020-0110 · Cited by 121
Sex‐related differences in COVID‐19 lethality
Penna, C. R. R., Mercurio, V., Tocchetti, C. G., & Pagliaro, P. (2020) · British Journal of Pharmacology · doi:10.1111/bph.15207 · Cited by 109
COVID-19 and diabetes: Association intensify risk factors for morbidity and mortality
Sharma, P., Behl, T., Sharma, N., Singh, S., Grewal, A. S., Albarrati, A., Albratty, M., Meraya, A. M., & BUNGAU, S. G. (2022) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2022.113089 · Cited by 116
COVID-19 and non-communicable diseases
Pal, R., & Bhadada, S. K. (2020) · Postgraduate Medical Journal · doi:10.1136/postgradmedj-2020-137742 · Cited by 94
Vasculopathy and Coagulopathy Associated with SARS-CoV-2 Infection
Labò, N., Ohnuki, H., & Tosato, G. (2020) · Cells · doi:10.3390/cells9071583 · Cited by 92
SARS-CoV-2 entry in host cells-multiple targets for treatment and prevention
Mahmoud, I. S., Jarrar, Y. B., Alshaer, W., & Ismail, S. I. (2020) · Biochimie · doi:10.1016/j.biochi.2020.05.012 · Cited by 83
Immunological Aspects of SARS-CoV-2 Infection and the Putative Beneficial Role of Vitamin-D
Peng, M.-Y., Liu, W.-C., Zheng, J.-Q., Lu, C., Hou, Y., Zheng, C., Song, J.-Y., Lu, K., & Chao, Y. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22105251 · Cited by 86
Multisystem inflammatory syndrome associated with COVID-19 from the pediatric emergency physician's point of view
Simon, H., Sakano, T. M. S., Rodrigues, R. M., Eisencraft, A. P., Carvalho, V. E. D. L., Schvartsman, C., & Reis, A. G. (2020) · Jornal de Pediatria · doi:10.1016/j.jped.2020.08.004 · Cited by 82
COVID-19: Yet another coronavirus challenge in transplantation
Aslam, S., & Mehra, M. R. (2020) · The Journal of Heart and Lung Transplantation · doi:10.1016/j.healun.2020.03.007 · Cited by 82
Alternative Roles of STAT3 and MAPK Signaling Pathways in the MMPs Activation and Progression of Lung Injury Induced by Cigarette Smoke Exposure in ACE2 Knockout Mice
Hung, Y.-H., Hsieh, W., Hsieh, J. S., Liu, F.-C., Tsai, C.-H., Lu, L.-C., Huang, C.-Y., Wu, C.-L., & Lin, C. (2016) · International Journal of Biological Sciences · doi:10.7150/ijbs.13379 · Cited by 81
COVID-19 and the kidney
Hassanein, M., Radhakrishnan, Y., Sedor, J. R., Vachharajani, T. J., Vachharajani, V., Augustine, J. J., Demirjian, S. G., & Thomas, G. (2020) · Cleveland Clinic Journal of Medicine · doi:10.3949/ccjm.87a.20072 · Cited by 83
Commentary: COVID-19 and diabetes mellitus: What we know, how our patients should be treated now, and what should happen next
Angelidi, A. M., Belanger, M. J., & Mantzoros, C. S. (2020) · Metabolism · doi:10.1016/j.metabol.2020.154245 · Cited by 86
The association of hypertension and diabetes pharmacotherapy with COVID-19 severity and immune signatures: an observational study
Dalan, R., Ang, L. W., Tan, W. Y. T., Fong, S., Tay, W. C., Chan, Y., Rénia, L., Ng, L. F. P., Lye, D. C., Chew, D. E. K., et al. (2020) · European Heart Journal - Cardiovascular Pharmacotherapy · doi:10.1093/ehjcvp/pvaa098 · Cited by 79
O Efeito da Doença de Coronavírus 2019 nas Doenças Cardiovasculares
Aşkın, L., Tanrıverdi, O., & Aşkın, H. Ş. (2020) · Arquivos Brasileiros de Cardiologia · doi:10.36660/abc.20200273 · Cited by 91
Resveratrol Inhibits Growth of Experimental Abdominal Aortic Aneurysm Associated With Upregulation of Angiotensin-Converting Enzyme 2
Moran, C. S., Biroš, E., Krishna, S. M., Wang, Y., Tikellis, C., Morton, S. K., Moxon, J. V., Cooper, M. E., Norman, P. E., Burrell, L. M., et al. (2017) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.117.310129 · Cited by 76
Self-citation
Diabetes and COVID-19: Global and regional perspectives
Jeong, I., Yoon, K., & Lee, M. K. (2020) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2020.108303 · Cited by 80
The renin-angiotensin-aldosterone system (RAAS) signaling pathways and cancer: foes versus allies
Hassani, B., Attar, Z., & Firouzabadi, N. (2023) · Cancer Cell International · doi:10.1186/s12935-023-03080-9 · Cited by 83
Therapeutic effect of human umbilical cord mesenchymal stem cells modified by angiotensin-converting enzyme 2 gene on bleomycin-induced lung fibrosis injury
MIN, F., GAO, F., Li, Q., & Liu, Z. (2014) · Molecular Medicine Reports · doi:10.3892/mmr.2014.3025 · Cited by 77
The relationship of stress and blood pressure effectors.
Ayada, C., Toru, Ü., & Korkut, Y. (2015) · Europe PMC (PubMed Central) · Cited by 80
Cardiovascular disease and COVID ‐19: Australian and New Zealand consensus statement
Zaman, S., MacIsaac, A. I., Jennings, G. L., Schlaich, M. P., Inglis, S. C., Arnold, R., Kumar, S., Thomas, L., Wahi, S., Lo, S., et al. (2020) · Medical Journal of Australia · doi:10.5694/mja2.50714 · Cited by 73
The value of ECG changes in risk stratification of COVID‐19 patients
Bergamaschi, L., D’Angelo, E. C., Paolisso, P., Toniolo, S., Fabrizio, M., Angeli, F., Donati, F., Magnani, I., Rinaldi, A., Bartoli, L., et al. (2021) · Annals of Noninvasive Electrocardiology · doi:10.1111/anec.12815 · Cited by 72
Diminazene aceturate prevents nephropathy by increasing glomerular ACE2 and AT2 receptor expression in a rat model of type1 diabetes
Goru, S. K., Kadakol, A., Malek, V., Pandey, A., Sharma, N., & Gaikwad, A. B. (2017) · British Journal of Pharmacology · doi:10.1111/bph.13946 · Cited by 72
The use of renin–angiotensin–aldosterone system (RAAS) inhibitors is associated with a lower risk of mortality in hypertensive COVID‐19 patients: A systematic review and meta‐analysis
Wang, Y., Chen, B., Li, Y., Zhang, L., Wang, Y., Yang, S., Xiao, X., & Qin, Q. (2020) · Journal of Medical Virology · doi:10.1002/jmv.26625 · Cited by 72
An ACE2 Microbody Containing a Single Immunoglobulin Fc Domain Is a Potent Inhibitor of SARS-CoV-2
Tada, T., Fan, C., Chen, J., Kaur, R., Stapleford, K. A., Gristick, H. B., Dcosta, B. M., Wilen, C. B., Nimigean, C. M., & Landau, N. R. (2020) · Cell Reports · doi:10.1016/j.celrep.2020.108528 · Cited by 72
The Perfect Storm: COVID-19 Health Disparities in US Blacks
Phillips, N., Park, I.-W., Robinson, J. R., & Jones, H. P. (2020) · Journal of Racial and Ethnic Health Disparities · doi:10.1007/s40615-020-00871-y · Cited by 77
A comprehensive review on rational and effective treatment strategies against an invisible enemy; SARS Cov-2 infection
Aktaş, G. (2020) · Experimental Biomedical Research · doi:10.30714/j-ebr.2020463629 · Cited by 72
Angiotensin-Converting-Enzyme 2 and Renin-Angiotensin System Inhibitors in COVID-19: An Update
Shukla, A. K., & Banerjee, M. (2021) · High Blood Pressure & Cardiovascular Prevention · doi:10.1007/s40292-021-00439-9 · Cited by 76
COVID-19 cardiovascular epidemiology, cellular pathogenesis, clinical manifestations and management
Sattar, Y., Ullah, W., Rauf, H., Virk, H. U. H., Yadav, S. K., Chowdhury, M., Connerney, M. A., Mamtani, S. S., Pahuja, M., Patel, R., et al. (2020) · IJC Heart & Vasculature · doi:10.1016/j.ijcha.2020.100589 · Cited by 68
COVID ‐19, microthromboses, inflammation, and platelet activating factor
Demopoulos, C. A., Antonopoulou, S., & Theoharides, T. C. (2020) · BioFactors · doi:10.1002/biof.1696 · Cited by 71
Promising phytochemicals of traditional Indian herbal steam inhalation therapy to combat COVID-19 – An in silico study
Gowrishankar, S., Muthumanickam, S., Kamaladevi, A., Karthika, C., Jothi, R., Boomi, P., Maniazhagu, D., & Pandian, S. K. (2021) · Food and Chemical Toxicology · doi:10.1016/j.fct.2020.111966 · Cited by 70
Role of the Renin–Angiotensin–Aldosterone and Kinin–Kallikrein Systems in the Cardiovascular Complications of COVID-19 and Long COVID
Cooper, S. L., Boyle, E., Jefferson, S. R., Heslop, C., Mohan, P., Mohanraj, G. G. J., Sidow, H. A., Tan, R. C. P., Hill, S. J., & Woolard, J. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22158255 · Cited by 70
Role of comorbidities like diabetes on severe acute respiratory syndrome coronavirus-2: A review
Das, S., Anu, K. R., Birangal, S., Nikam, A. N., Pandey, A. P., Mutalik, S., & Joseph, A. (2020) · Life Sciences · doi:10.1016/j.lfs.2020.118202 · Cited by 69
Vitamin A in resistance to and recovery from infection: relevance to SARS-CoV2
Stephensen, C. B., & Lietz, G. (2021) · British Journal Of Nutrition · doi:10.1017/s0007114521000246 · Cited by 66
Epithelial and Endothelial Expressions of ACE2: SARS-CoV-2 Entry Routes
Güney, C., & Akar, F. (2021) · Journal of Pharmacy & Pharmaceutical Sciences · doi:10.18433/jpps31455 · Cited by 66
Advanced glycation end products (AGEs) and its receptor, RAGE, modulate age-dependent COVID-19 morbidity and mortality. A review and hypothesis
Sellegounder, D., Zafari, P., Rajabinejad, M., Taghadosi, M., & Kapahi, P. (2021) · International Immunopharmacology · doi:10.1016/j.intimp.2021.107806 · Cited by 70
Molecular Pathogenesis, Immunopathogenesis and Novel Therapeutic Strategy Against COVID-19
Chatterjee, S. K., Saha, S., & Muñoz, M. N. M. (2020) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2020.00196 · Cited by 65
Association of vitamin D with the modulation of the disease severity in COVID-19
Mardani, R., Alamdary, A., Nasab, S. D. M., Gholami, R., Ahmadi, N., & Gholami, A. (2020) · Virus Research · doi:10.1016/j.virusres.2020.198148 · Cited by 65
Ambient PM2.5 exposure and rapid spread of COVID-19 in the United States
Chakrabarty, R. K., Beeler, P., Liu, P., Goswami, S., Harvey, R. D., Pervez, S., van Donkelaar, A., & Martin, R. V. (2020) · The Science of The Total Environment · doi:10.1016/j.scitotenv.2020.143391 · Cited by 67
Potential Role of Antioxidant and Anti-Inflammatory Therapies to Prevent Severe SARS-Cov-2 Complications
Pasini, A. M. F., Stranieri, C., Cominacini, L., & Mozzini, C. (2021) · Antioxidants · doi:10.3390/antiox10020272 · Cited by 68
Immunosenescence and inflamm-ageing in COVID-19
Zinatizadeh, M. R., Zarandi, P. K., Ghiasi, M., Kooshki, H., Mohammadi, M., Amani, J., & Rezaei, N. (2022) · Ageing Research Reviews · doi:10.1016/j.arr.2022.101818 · Cited by 69
Arterial Hypertension as a Risk Comorbidity Associated with COVID‐19 Pathology
Kamyshnyi, O., Krynytska, І., Matskevych, V. M., Марущак, М. І., & Lushchak, O. V. (2020) · International Journal of Hypertension · doi:10.1155/2020/8019360 · Cited by 76
COVID‐19 and immunothrombosis: emerging understanding and clinical management
Shaw, R., Bradbury, C. A., Abrams, S. T., Wang, G., & Toh, C. (2021) · British Journal of Haematology · doi:10.1111/bjh.17664 · Cited by 60
Mechanisms of COVID-19-induced kidney injury and current pharmacotherapies
Faour, W. H., Choaib, A., Issa, E., Choueiry, F. E., Shbaklo, K., Alhajj, M., Sawaya, R. T., Harhous, Z., Alefishat, E. A., & Nader, M. (2021) · Inflammation Research · doi:10.1007/s00011-021-01520-8 · Cited by 63
Marked Up-Regulation of ACE2 in Hearts of Patients With Obstructive Hypertrophic Cardiomyopathy: Implications for SARS-CoV-2–Mediated COVID-19
Bos, J. M., Hebl, V. B., Oberg, A. L., Sun, Z., Herman, D. S., Teekakirikul, P., Seidman, J. G., Seidman, C. E., dos Remedios, C. G., Maleszewski, J. J., et al. (2020) · Mayo Clinic Proceedings · doi:10.1016/j.mayocp.2020.04.028 · Cited by 64
Classical and alternative receptors for SARS‐CoV‐2 therapeutic strategy
Masre, S. F., Jufri, N. F., Ibrahim, F. W., & Raub, S. H. A. (2020) · Reviews in Medical Virology · doi:10.1002/rmv.2207 · Cited by 62
Supervised molecular dynamics for exploring the druggability of the SARS-CoV-2 spike protein
Deganutti, G., Prischi, F., & Reynolds, C. A. (2020) · Journal of Computer-Aided Molecular Design · doi:10.1007/s10822-020-00356-4 · Cited by 63
A Review on the Neurological Manifestations of COVID-19 Infection: a Mechanistic View
Zangbar, H. S., Gorji, A., & Ghadiri, T. (2020) · Molecular Neurobiology · doi:10.1007/s12035-020-02149-0 · Cited by 57
Obesity, Diabetes and COVID-19: An Infectious Disease Spreading From the East Collides With the Consequences of an Unhealthy Western Lifestyle
Holly, J. M. P., Biernacka, K. M., Maskell, N. A., & Perks, C. M. (2020) · Frontiers in Endocrinology · doi:10.3389/fendo.2020.582870 · Cited by 56
Computational biophysical characterization of the SARS-CoV-2 spike protein binding with the ACE2 receptor and implications for infectivity
Chowdhury, R., Boorla, V. S., & Maranas, C. D. (2020) · Computational and Structural Biotechnology Journal · doi:10.1016/j.csbj.2020.09.019 · Cited by 56

Authors: Tikellis, C., & Thomas, M. C.
Affiliations: Baker Heart and Diabetes Institute (AU)
Corresponding author: Tikellis, Chris
ORCID: Thomas, M. C.
Venue: International Journal of Peptides
Publisher: Hindawi Limited
Published: 2012-03-20
Volume: 2012
Pages: 1-8
ISSN: 1687-9767 (ISSN-L)
1687-9775
DOI: 10.1155/2012/256294
PMC: PMC3321295
OpenAlex: W2082133861
Cited by: 624
References: 85
Citations by year: 2026: 8 · 2025: 11 · 2024: 31 · 2023: 57 · 2022: 87 · 2021: 164 · 2020: 244 · 2019: 7 · 2018: 2 · 2017: 3 · 2016: 2 · 2015: 5 · 2014: 3
FWCI: 1.65
Type: journal article
Language: en
Open access: hybrid
doi.org
Licence: cc-by
creativecommons.org/licenses/by/3.0/ (unspecified)
Locations: International Journal of Peptides (publishedVersion, cc-by)
Europe PMC (PubMed Central) (publishedVersion, cc-by)
PubMed Central (publishedVersion, cc-by)
PubMed (publishedVersion)
Minerva Access (University of Melbourne) (submittedVersion, cc-by)
Funders: National Health and Medical Research Council
Topics: Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Renin-Angiotensin System Studies
Health Sciences › Medicine › Hematology › Coagulation, Bradykinin, Polyphosphates, and Angioedema
Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Eicosanoids and Hypertension Pharmacology
Keywords: angiotensin-converting enzyme 2, renin-angiotensin system, angiotensin II, angiotensin-(1-7), hypertension, diabetes mellitus, cardiovascular disease, organ protection

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Angiotensin-Converting Enzyme 2 (ACE2) Is a Key Modulator of the Renin Angiotensin System in Health and Disease

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks